Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D Novack

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Journal of Glaucoma|June 17, 1998
Ophthalmic drug development: procedural considerationsG D Novack
American Journal of Ophthalmology|September 15, 1992
The development of new drugs for ophthalmologyG D Novack
Journal of Glaucoma|January 1, 1992
Prelude to an outcomeG D Novack
American Journal of Ophthalmology|November 18, 2000
Update on regulatory review intervals for ophthalmic new drug applications at the United States Food and Drug AdministrationG D Novack
Proceedings of the Western Pharmacology Society|January 1, 1978
Effects of histamine on three organ systemsG D Novack
General Pharmacology|January 1, 1986
Levobunolol for the long-term treatment of glaucomaG D Novack
American Journal of Ophthalmology|April 15, 1988
The effect of twice daily nadolol on intraocular pressureG D Novack
Investigative Ophthalmology & Visual Science|November 5, 1999
ARVO Commercial Relationships Policy: financial disclosure in ARVO presentations and publications. Association for Research in Vision and Ophthalmology, IncG D Novack
Current Opinion in Ophthalmology|November 4, 1994
Ocular toxicologyG D Novack
Current Opinion in Ophthalmology|November 4, 1995
Ocular toxicologyG D Novack
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Journal of Glaucoma|June 17, 1998
Ophthalmic drug development: procedural considerationsG D Novack
American Journal of Ophthalmology|September 15, 1992
The development of new drugs for ophthalmologyG D Novack
Journal of Glaucoma|January 1, 1992
Prelude to an outcomeG D Novack
American Journal of Ophthalmology|November 18, 2000
Update on regulatory review intervals for ophthalmic new drug applications at the United States Food and Drug AdministrationG D Novack
Proceedings of the Western Pharmacology Society|January 1, 1978
Effects of histamine on three organ systemsG D Novack
General Pharmacology|January 1, 1986
Levobunolol for the long-term treatment of glaucomaG D Novack
American Journal of Ophthalmology|April 15, 1988
The effect of twice daily nadolol on intraocular pressureG D Novack
Investigative Ophthalmology & Visual Science|November 5, 1999
ARVO Commercial Relationships Policy: financial disclosure in ARVO presentations and publications. Association for Research in Vision and Ophthalmology, IncG D Novack
Current Opinion in Ophthalmology|November 4, 1994
Ocular toxicologyG D Novack
Current Opinion in Ophthalmology|November 4, 1995
Ocular toxicologyG D Novack
Pageof 8